Literature DB >> 29091184

Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.

Marine Perrier1, Mélanie Bertine1, Quentin Le Hingrat1, Véronique Joly2, Benoit Visseaux1, Gilles Collin1, Roland Landman2, Yazdan Yazdanpanah2, Diane Descamps1,3, Charlotte Charpentier1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29091184     DOI： 10.1093/jac/dkx208

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  12 in total

1.  Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

Authors:  Jimmy P Xu; Ashwanth C Francis; Megan E Meuser; Marie Mankowski; Roger G Ptak; Adel A Rashad; Gregory B Melikyan; Simon Cocklin
Journal:  J Drug Des Res       Date:  2018-08-13

Review 2.  Novel Antiretroviral Agents.

Authors:  Mary C Cambou; Raphael J Landovitz
Journal:  Curr HIV/AIDS Rep       Date:  2020-04       Impact factor: 5.071

Review 3.  Inhibitors of the HIV-1 capsid, a target of opportunity.

Authors:  Stephanie K Carnes; Jonathan H Sheehan; Christopher Aiken
Journal:  Curr Opin HIV AIDS       Date:  2018-07       Impact factor: 4.283

Review 4.  Restriction of HIV-1 and other retroviruses by TRIM5.

Authors:  Barbie K Ganser-Pornillos; Owen Pornillos
Journal:  Nat Rev Microbiol       Date:  2019-07-16       Impact factor: 60.633

5.  A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.

Authors:  Da-Wei Zhang; Rong-Hua Luo; Lei Xu; Liu-Meng Yang; Xiao-Shuang Xu; Gregory J Bedwell; Alan N Engelman; Yong-Tang Zheng; Shan Chang
Journal:  Antiviral Res       Date:  2019-06-27       Impact factor: 5.970

6.  Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.

Authors:  Lin Sun; Alexej Dick; Megan E Meuser; Tianguang Huang; Waleed A Zalloum; Chin-Ho Chen; Srinivasulu Cherukupalli; Shujing Xu; Xiao Ding; Ping Gao; Dongwei Kang; Erik De Clercq; Christophe Pannecouque; Simon Cocklin; Kuo-Hsiung Lee; Xinyong Liu; Peng Zhan
Journal:  J Med Chem       Date:  2020-04-29       Impact factor: 7.446

Review 7.  Long-acting drugs and formulations for the treatment and prevention of HIV infection.

Authors:  Charles Flexner; Andrew Owen; Marco Siccardi; Susan Swindells
Journal:  Int J Antimicrob Agents       Date:  2020-11-06       Impact factor: 5.283

8.  Clinical targeting of HIV capsid protein with a long-acting small molecule.

Authors:  John O Link; Martin S Rhee; Winston C Tse; Jim Zheng; John R Somoza; William Rowe; Rebecca Begley; Anna Chiu; Andrew Mulato; Derek Hansen; Eric Singer; Luong K Tsai; Rujuta A Bam; Chien-Hung Chou; Eda Canales; Gediminas Brizgys; Jennifer R Zhang; Jiayao Li; Michael Graupe; Philip Morganelli; Qi Liu; Qiaoyin Wu; Randall L Halcomb; Roland D Saito; Scott D Schroeder; Scott E Lazerwith; Steven Bondy; Debi Jin; Magdeleine Hung; Nikolai Novikov; Xiaohong Liu; Armando G Villaseñor; Carina E Cannizzaro; Eric Y Hu; Robert L Anderson; Todd C Appleby; Bing Lu; Judy Mwangi; Albert Liclican; Anita Niedziela-Majka; Giuseppe A Papalia; Melanie H Wong; Stephanie A Leavitt; Yili Xu; David Koditek; George J Stepan; Helen Yu; Nikos Pagratis; Sheila Clancy; Shekeba Ahmadyar; Terrence Z Cai; Scott Sellers; Scott A Wolckenhauer; John Ling; Christian Callebaut; Nicolas Margot; Renee R Ram; Ya-Pei Liu; Rob Hyland; Gary I Sinclair; Peter J Ruane; Gordon E Crofoot; Cheryl K McDonald; Diana M Brainard; Latesh Lad; Swami Swaminathan; Wesley I Sundquist; Roman Sakowicz; Anne E Chester; William E Lee; Eric S Daar; Stephen R Yant; Tomas Cihlar
Journal:  Nature       Date:  2020-07-01       Impact factor: 49.962

Review 9.  Rotten to the core: antivirals targeting the HIV-1 capsid core.

Authors:  William M McFadden; Alexa A Snyder; Karen A Kirby; Philip R Tedbury; Monika Raj; Zhengqiang Wang; Stefan G Sarafianos
Journal:  Retrovirology       Date:  2021-12-22       Impact factor: 3.768

Review 10.  HIV Capsid Inhibitors Beyond PF74.

Authors:  Carole McArthur; Fabio Gallazzi; Thomas P Quinn; Kamal Singh
Journal:  Diseases       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.